Rockefeller Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4K Buy
50
+15
+43% +$3.36K ﹤0.01% 3940
2025
Q4
$7.46K Sell
35
-77
-69% -$15.9K ﹤0.01% 3934
2025
Q3
$22.3K Buy
+112
New +$20.9K ﹤0.01% 3306
2023
Q1
Sell
-24
Closed -$1K 2098
2022
Q4
$1K Buy
24
+8
+50% +$929 ﹤0.01% 3638
2022
Q3
$1K Sell
16
-112
-88% -$10.6K ﹤0.01% 3668
2022
Q2
$11K Buy
128
+118
+1,180% +$11.1K ﹤0.01% 3051
2022
Q1
$1K Sell
10
-19
-66% -$2.2K ﹤0.01% 3697
2021
Q4
$3K Buy
+29
New +$4.31K ﹤0.01% 3407
2021
Q3
Sell
-50
Closed -$6K 3687
2021
Q2
$6K Hold
50
﹤0.01% 2955
2021
Q1
$6K Buy
+50
New +$7.6K ﹤0.01% 2814
2020
Q2
Sell
-100
Closed -$11K 2572
2020
Q1
$11K Hold
100
﹤0.01% 1706
2019
Q4
$14K Hold
100
﹤0.01% 1497
2019
Q3
$10K Hold
100
﹤0.01% 1406
2019
Q2
$12K Hold
100
﹤0.01% 1165
2019
Q1
$12K Buy
+100
New +$8.76K ﹤0.01% 1421

Other funds holding ASND